This is consistent with a previous study that reported its upregulation in T-cell acute lymphoblastic leukemia (T-ALL) compared to healthy controls due to the action of the Notch pathway and NF-κB, which are important in cancer pathogenesis [45]. This evidence concerns the gene NFKB1 and T-cell acute lymphoblastic leukemia.